TD Cowen raises Procter & Gamble stock price target on turnaround progress

TD Cowen raised its price target for Procter & Gamble (NYSE:PG) to $166 from $150, citing strong Q1 performance and potential for full-year guidance. The firm maintained a Hold rating due to uncertainty about U.S. momentum. PG reported Q1 earnings of $2.00 per share on $23.28B revenue, exceeding estimates. Morgan Stanley also raised its target to $185, highlighting profit upside.

Original reporting
Published Oct 23, 2026, 2:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bullish
high confidence
Mentioned
$PG
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PGBullishHigh
01

Why it matters

The earnings beat and target raise could drive short‑term buying interest in PG.

02

Market read

Positive earnings surprise and analyst upgrade suggest upside for PG and potentially related consumer staples.

03

What to watch

Rising raw material and freight costs could pressure margins despite the beat.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

TD Cowen raised its price target on PG to $166 from $150 after the company posted a strong Q1 earnings beat.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

Procter & Gamble reported fiscal Q1 earnings beat with $2.00 EPS and $23.28B revenue, prompting TD Cowen to raise its price target to $166.

Expected impact

likely upward pressure as investors price in the earnings beat and higher target.

Evidence & confidence

Strong top‑line growth and analyst target raise indicate improved fundamentals.

Market effects

Consumer staples may see broader optimism from a major player beating expectations.

U.S. market sentiment likely improves for consumer goods stocks.

Limited to U.S. equities; no direct global impact.

Counterpoint

Hold rating reflects uncertainty about sustainability of momentum and pricing power.

Key entities

  • Procter & Gamble

    Consumer goods conglomerate reporting Q1 earnings.

  • TD Cowen

    Equity research firm raising PG price target.

Related articles

$PGMed

P&G Plans To Cut Up To 30% Product Supply Jobs By 2030; Confirms FY27 Outlook

Procter & Gamble (P&G) plans to cut 20-30% of product supply jobs by 2030, aiming for $10B in productivity savings. The company maintained its FY27 outlook, projecting 2-4% net sales growth and 1-3% organic sales growth. P&G also expects $1.8B in annual productivity savings and $30B in growth opportunities. Shares gained 0.30% to $168.35 in overnight trading.

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November